Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Cervical Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 207 articles: HTML format

Single Articles

March 2026
1. CUI YM, Shan YM, Xiao YY, Gao Y, et al
   Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
   BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
   PubMed    
   
   
   
2. OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
   Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
   BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
   PubMed    
   
   
   
3. WU M, Jiang Z, Xian X, Lu M, et al
   Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
   BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
   PubMed    
   
   
   
4. CHEN X, Li J, Sun Y, Ye Z, et al
   LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
   BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
   PubMed    
   
   
   
5. ABERA GB, Alemayehu M, Sori DA, Ali R, et al
   Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
   BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
   PubMed     Abstract available
   
   
   February 2026
6. BONNAH J, Awuah B, Williams MS
   The role of healthcare providers in shared decision making for cervical cancer prevention in Ghana: A qualitative study.
   BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15785.
   PubMed    
   
   
   
7. WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
   Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
   BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
   PubMed    
   
   
   
8. ANENA S, Okello MO, Ouma RC, Olum R, et al
   Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
   BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
   PubMed    
   
   
   
9. FEI C, Chen W, Liu J, Wang J, et al
   A real-world multicenter study on opportunistic cervical cancer screening in hospital in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions.
   BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
   PubMed    
   
   
   January 2026
10. LIN S, Zhong J, Yuan S, Su M, et al
    Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.
    BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15636.
    PubMed     Abstract available
    
    
    
11. YANG XL, He JL, Wang TJ, Ran L, et al
    Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
    BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15661.
    PubMed     Abstract available
    
    
    
12. GUO W, Jian W, Zhu L, Zhang B, et al
    3D transformer-based dose prediction in HDR brachytherapy for cervical cancer.
    BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-026-15592.
    PubMed    
    
    
    
13. WANG Y, Deng Y, Wei Y, Wang C, et al
    Association of SMAD4 gene polymorphisms with human papillomavirus infection and risk of cervical cancer: a case-control study.
    BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15552.
    PubMed    
    
    
    December 2025
14. GAN S, Tang J, Qin S, Ou Q, et al
    Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
    PubMed     Abstract available
    
    
    
15. HAN X, Di R, Zhang H, Zhou B, et al
    Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
    PubMed     Abstract available
    
    
    
16. TESFAW A, Addissie A, Kantelhardt EJ, Getachew S, et al
    Survival status and predictors of mortality among patients with cervical cancer in two oncology units in Northwest Ethiopia: a retrospective follow-up study.
    BMC Cancer. 2025 Dec 17. doi: 10.1186/s12885-025-15444.
    PubMed    
    
    
    
17. ZHAI X, Kong T, Yang X, Yu J, et al
    Clinical performance of triage strategies for HPV-positive women in cervical cancer screening in rural Yunnan China.
    BMC Cancer. 2025 Dec 3. doi: 10.1186/s12885-025-15375.
    PubMed     Abstract available
    
    
    November 2025
18. XU L, Guo R, Tang F, Sun X, et al
    Dosimetric analysis of plans using x-ray and gamma-ray combination strategy for advanced cervical cancer patients with pelvic lymph node metastasis.
    BMC Cancer. 2025;25:1836.
    PubMed     Abstract available
    
    
    
19. PAN J, Wei W, Dai B, Wang Y, et al
    Restricted spectrum imaging and diffusion kurtosis imaging for assessing lymph node metastasis in cervical cancer: a histogram analysis-based study.
    BMC Cancer. 2025;25:1817.
    PubMed     Abstract available
    
    
    
20. SU R, Yang D, Chen S, Ding X, et al
    Impact of laparoscopic surgical proficiency on survival outcomes in laparoscopic radical hysterectomy for cervical cancer: a multi-center cohort study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15220.
    PubMed     Abstract available
    
    
    
21. KANG Y, Chang L, Lin H, Liu J, et al
    Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
    PubMed     Abstract available
    
    
    
22. BARDOE D
    Predictors of non-screening for cervical cancer in Ghana: an application of Andersen's behavioural model of health services use among pregnant women in Pru East municipality.
    BMC Cancer. 2025;25:1783.
    PubMed     Abstract available
    
    
    
23. DOFUTSU M, Aichi M, Itai T, Shinoda S, et al
    Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study.
    BMC Cancer. 2025;25:1762.
    PubMed    
    
    
    
24. VENGHATERI JB, Nathani P, Goyal S, Sarang B, et al
    Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs.
    BMC Cancer. 2025;25:1724.
    PubMed     Abstract available
    
    
    
25. ZHOU Y, Guo X, Han J, Ding W, et al
    DDR1 drives cervical cancer progression and immune evasion: a bioinformatics analysis with experimental verification.
    BMC Cancer. 2025;25:1716.
    PubMed     Abstract available
    
    
    October 2025
26. ABUBAKAR BG
    Taking it to their doorstep: outreach well-woman clinics in brothels for cervical cancer screening of female sex workers in North-Western Nigeria.
    BMC Cancer. 2025;25:1660.
    PubMed     Abstract available
    
    
    
27. LI N, Yu Z, Li X, Gao Y, et al
    The rationality of negative margin criteria for conization in early cervical cancer - a cohort study.
    BMC Cancer. 2025;25:1640.
    PubMed     Abstract available
    
    
    
28. JIANG P, Wei S, Li C, Qu A, et al
    Safety and efficacy of toripalimab plus concurrent chemoradiotherapy for locally advanced cervical cancer: a single-arm, phase Ib trial.
    BMC Cancer. 2025;25:1566.
    PubMed     Abstract available
    
    
    
29. TESFOM HN, Gizaw M, Yilam M, Klein JMA, et al
    Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia.
    BMC Cancer. 2025;25:1557.
    PubMed     Abstract available
    
    
    
30. SETSOAFIA EA, Sarfo-Annan G, Daniels J, Addae J, et al
    Experiences of patients with cervical cancer undergoing concurrent chemoradiation therapy at the Korle-Bu teaching hospital in Ghana: an explorative qualitative study.
    BMC Cancer. 2025;25:1547.
    PubMed     Abstract available
    
    
    
31. KONG L, Xiao X, Wan R, Zhao S, et al
    Immediate risk and 5-year cumulative risk of high-grade cervical lesions in high-risk HPV-positive patients with minor cytological abnormalities: a retrospective single-center study in China.
    BMC Cancer. 2025;25:1541.
    PubMed     Abstract available
    
    
    
32. LAI R, Tan Q, Ding C, Xu Y, et al
    Habitat-based transformer model in pretreatment (18)F-FDG PET imaging for predicting prognosis in cervical cancer: a two-center retrospective study.
    BMC Cancer. 2025;25:1515.
    PubMed     Abstract available
    
    
    
33. ZHU J, Zhou Q, Chen L, He Z, et al
    Predicting hematologic toxicity in advanced cervical cancer patients using interpretable machine learning models based on radiomics and dosimetrics.
    BMC Cancer. 2025;25:1516.
    PubMed     Abstract available
    
    
    
34. SONG Y, Qin H, Huang S, Wang J, et al
    alpha-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis.
    BMC Cancer. 2025;25:1503.
    PubMed     Abstract available
    
    
    
35. LI X, Mao Z, Li Q, He M, et al
    Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective study.
    BMC Cancer. 2025;25:1498.
    PubMed     Abstract available
    
    
    
36. BRUNO MT, Cavallaro AG, Sudano MC, Fratto MC, et al
    Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.
    BMC Cancer. 2025;25:1486.
    PubMed     Abstract available
    
    
    September 2025
37. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
    Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
    BMC Cancer. 2025;25:1469.
    PubMed     Abstract available
    
    
    
38. YANG Q, Han X
    Prognostic value of risk factors in cervical squamous cell carcinoma based on tumour infiltration depth.
    BMC Cancer. 2025;25:1412.
    PubMed     Abstract available
    
    
    August 2025
39. LIM MSH, Tan SSN, Wan Maharuddin IB, Voon PJ, et al
    Survival rates of cervical cancer patients in Sarawak: a single-centre referral study.
    BMC Cancer. 2025;25:1381.
    PubMed    
    
    
    
40. ZHANG Z, Wu H, Huang Y, Wei Y, et al
    High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses.
    BMC Cancer. 2025;25:1350.
    PubMed     Abstract available
    
    
    
41. MUSHUMBUSI A, Kaizilege G, Chibwe E, Ottoman O, et al
    Three-year survival outcomes following radical hysterectomy in early-stage cervical carcinoma: A study at Bugando medical centre, Mwanza, Tanzania.
    BMC Cancer. 2025;25:1343.
    PubMed     Abstract available
    
    
    
42. LI YX, Cao SY, Fan Y, Zhang YF, et al
    Survival outcomes in IIIC cervical cancer by treatment strategies: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1340.
    PubMed     Abstract available
    
    
    
43. CHENG L, Xu Y, Li Z, Sun D, et al
    DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment.
    BMC Cancer. 2025;25:1291.
    PubMed     Abstract available
    
    
    
44. HAN S, Qin Y, He Y, Li M, et al
    LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells.
    BMC Cancer. 2025;25:1279.
    PubMed     Abstract available
    
    
    
45. ZHANG B, Li Z, Yang Z, Yin Y, et al
    Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.
    BMC Cancer. 2025;25:1269.
    PubMed     Abstract available
    
    
    
46. TUPA F, Ruwaichi T, Luoga P, Mwaiselage J, et al
    Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania.
    BMC Cancer. 2025;25:1259.
    PubMed     Abstract available
    
    
    July 2025
47. YAO X, Qie M, Kang L, Li M, et al
    Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
    BMC Cancer. 2025;25:1238.
    PubMed     Abstract available
    
    
    
48. JI H, Zheng J, Liu L, Liu Q, et al
    LAMP3 signature affects cervical cancer progression through autophagy.
    BMC Cancer. 2025;25:1206.
    PubMed     Abstract available
    
    
    
49. HUANG Y, Shen Y, Wei X, Feng J, et al
    Predictive value of vaginal lactic acid bacteria changes on occurrence of HR-HPV-infected cervical intraepithelial neoplasia and construction and validation of nomogram model.
    BMC Cancer. 2025;25:1212.
    PubMed     Abstract available
    
    
    
50. REN Y, Qin F, Shen L, Li L, et al
    Triage of women with a positive HPV DNA test: evaluating a DNA methylation panel for detecting cervical intraepithelial neoplasia grade 3 and cervical cancer in cervical cytology samples.
    BMC Cancer. 2025;25:1207.
    PubMed     Abstract available
    
    
    
51. IROWA O, Adeyeye OS, Ujah OI, Ogwuche PE, et al
    Assessment of barriers to cervical cancer screening at primary health care centers in Makurdi, North-Central Nigeria: a mixed-methods study.
    BMC Cancer. 2025;25:1099.
    PubMed     Abstract available
    
    
    
52. TONGHUI B, Wufen L, Lin Q
    Single-cell sequencing reveals the role of SALL4 in cervical cancer development.
    BMC Cancer. 2025;25:1086.
    PubMed     Abstract available
    
    
    
53. MANDIWA C, Sanna M, Gao W
    Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
    BMC Cancer. 2025;25:1052.
    PubMed     Abstract available
    
    
    
54. SEIFU BL, Asnake AA, Belayneh T, Hailemariam T, et al
    Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022.
    BMC Cancer. 2025;25:1067.
    PubMed     Abstract available
    
    
    
55. SHARMA U, Yadav BK, Rai U, Pradhan A, et al
    Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.
    BMC Cancer. 2025;25:1098.
    PubMed     Abstract available
    
    
    May 2025
56. YE Y, Chen Y, Pan J, Li P, et al
    Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a step forward in precision oncology.
    BMC Cancer. 2025;25:963.
    PubMed     Abstract available
    
    
    
57. WANG Y, Lin AY, Wang DD, Lin PP, et al
    In situ phenotypic and karyotypic co-detection of aneuploid TCs and TECs in cytological specimens with abnormal cervical screening results.
    BMC Cancer. 2025;25:945.
    PubMed     Abstract available
    
    
    
58. LI K, Huang F, Zhang T, Yang F, et al
    HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.
    BMC Cancer. 2025;25:885.
    PubMed     Abstract available
    
    
    
59. LI ZR, Wang YF, Zuo CR, Men JS, et al
    Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:863.
    PubMed     Abstract available
    
    
    April 2025
60. YOON HY, Kim JM, Jeong YY, Lee YH, et al
    Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion.
    BMC Cancer. 2025;25:811.
    PubMed     Abstract available
    
    
    
61. KHIARI H, Abdelfatteh YB, Mahjoub N, Mekni K, et al
    Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).
    BMC Cancer. 2025;25:739.
    PubMed     Abstract available
    
    
    
62. ZHANG C, Chen L
    6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
    BMC Cancer. 2025;25:719.
    PubMed     Abstract available
    
    
    
63. XAVIER SP, Galvao ND, das Neves MAB, da Silva KM, et al
    Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.
    BMC Cancer. 2025;25:684.
    PubMed     Abstract available
    
    
    
64. GE Y, Wu F, Zhang Y, Wang X, et al
    Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation.
    BMC Cancer. 2025;25:624.
    PubMed     Abstract available
    
    
    
65. TAGHADOS Z, Azimifar Z, Monsefi M, Jahromi MA, et al
    CausalCervixNet: convolutional neural networks with causal insight (CICNN) in cervical cancer cell classification-leveraging deep learning models for enhanced diagnostic accuracy.
    BMC Cancer. 2025;25:607.
    PubMed     Abstract available
    
    
    March 2025
66. WEN K, Wang L, Su H, Yu L, et al
    Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer.
    BMC Cancer. 2025;25:580.
    PubMed     Abstract available
    
    
    
67. ZHOU R, Xie Y, Wang Z, Liu Z, et al
    Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and identifies a prognostic signature in cervical cancer.
    BMC Cancer. 2025;25:498.
    PubMed     Abstract available
    
    
    
68. ZENG S, Li X, Xiao S, Yang P, et al
    Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:502.
    PubMed     Abstract available
    
    
    
69. CAI G, Zhang S, Gao S, Deng T, et al
    What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:491.
    PubMed     Abstract available
    
    
    
70. LUO D, Yu Y, Wang Q, Peng T, et al
    The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis.
    BMC Cancer. 2025;25:450.
    PubMed     Abstract available
    
    
    February 2025
71. JIA SZ, Yang XJ, Yang D, Wang R, et al
    Low pretreatment prognostic nutritional index predicts unfavorable survival in stage III-IVA squamous cervical cancer undergoing chemoradiotherapy.
    BMC Cancer. 2025;25:377.
    PubMed     Abstract available
    
    
    
72. WU C, Lv X, Wang F, Xu Q, et al
    Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer.
    BMC Cancer. 2025;25:364.
    PubMed     Abstract available
    
    
    
73. WU R, Wei Y, Wu A, Huang J, et al
    Performance of a six-methylation-marker assay in predicting LEEP specimen histology results of cervical HSIL patients: a retrospective study.
    BMC Cancer. 2025;25:340.
    PubMed     Abstract available
    
    
    
74. KUMAR S, Das B, Maurya G, Dey S, et al
    Limonoid-rich fraction from Azadirachta indica A. Juss. (neem) stem bark triggers ROS-independent ER stress and induces apoptosis in 2D cultured cervical cancer cells and 3D cervical tumor spheroids.
    BMC Cancer. 2025;25:334.
    PubMed     Abstract available
    
    
    
75. LI Y, Song W, Gao P, Guan X, et al
    Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.
    BMC Cancer. 2025;25:330.
    PubMed     Abstract available
    
    
    
76. ZHOU K, Wang C, Zhao J, Chen J, et al
    Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer.
    BMC Cancer. 2025;25:324.
    PubMed     Abstract available
    
    
    
77. BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al
    Correction: Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
    BMC Cancer. 2025;25:320.
    PubMed    
    
    
    
78. OKYERE J
    Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey.
    BMC Cancer. 2025;25:259.
    PubMed     Abstract available
    
    
    
79. BEHERY MB, Bahbah AA, Mohamed Shawqi M, El-Said YM, et al
    Knowledge, attitude, and practice towards uterine cervical cancer screening in Egyptian females: a nationwide cross-sectional study.
    BMC Cancer. 2025;25:237.
    PubMed     Abstract available
    
    
    
80. WANG Y, Yu Y, Gu L, Sun Y, et al
    Radiomics feature is a risk factor for locally advanced cervical cancer treated using concurrent chemoradiotherapy based on magnetic resonance imaging: a retrospective study.
    BMC Cancer. 2025;25:230.
    PubMed     Abstract available
    
    
    
81. SWASE TD, Fasogbon IV, Eseoghene IJ, Etukudo EM, et al
    The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers.
    BMC Cancer. 2025;25:202.
    PubMed     Abstract available
    
    
    
82. ANANGWE N, Steimgrimson J, Cu-Uvin S
    Evaluation of pathology resources for cervical cancer detection between 2018 and 2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.
    BMC Cancer. 2025;25:203.
    PubMed     Abstract available
    
    
    
83. MA H, Ma L, Yang L, Cai M, et al
    Construction and evaluation of a prognostic model for cervical cancer based on dynamic hematological and clinical features.
    BMC Cancer. 2025;25:207.
    PubMed     Abstract available
    
    
    January 2025
84. PINTO-SANTINI D, Jalil EM, Fernandes GT, Hilaire G, et al
    ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIV.
    BMC Cancer. 2025;25:151.
    PubMed     Abstract available
    
    
    
85. WAGNER-LARSEN KS, Lura N, Gulati A, Ryste S, et al
    MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.
    BMC Cancer. 2025;25:122.
    PubMed     Abstract available
    
    
    
86. KHASAWNEH AI, Al Shboul S, Himsawi N, Al Rousan A, et al
    Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue.
    BMC Cancer. 2025;25:111.
    PubMed     Abstract available
    
    
    
87. BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
    Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
    BMC Cancer. 2025;25:72.
    PubMed     Abstract available
    
    
    
88. GARG P, Krishnamoorthy Y, Halder P, Rajaa S, et al
    Urban-rural disparities in cervical cancer screening among Indian women between 30-49 years: a geospatial and decomposition analysis using a nationally representative survey.
    BMC Cancer. 2025;25:67.
    PubMed     Abstract available
    
    
    
89. SHEN T, Dong T, Wang H, Ding Y, et al
    Integrative machine learning frameworks to uncover specific protein signature in neuroendocrine cervical carcinoma.
    BMC Cancer. 2025;25:57.
    PubMed     Abstract available
    
    
    
90. BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al
    Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
    BMC Cancer. 2025;25:4.
    PubMed     Abstract available
    
    
    December 2024
91. ZHANG Z, Xie C, Zhao R, Wang S, et al
    Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions.
    BMC Cancer. 2024;24:1582.
    PubMed     Abstract available
    
    
    
92. SUN D, Shu C, Zeng F, Xu D, et al
    The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.
    BMC Cancer. 2024;24:1514.
    PubMed     Abstract available
    
    
    
93. LIU Q, Zhu J, Abulizi G, Hasim A, et al
    Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma.
    BMC Cancer. 2024;24:1504.
    PubMed     Abstract available
    
    
    
94. XIA W, Dai X, Hu Y, Yang S, et al
    Value of intraoperative post-conisation human papillomavirus testing in predicting residual or recurrence after treatment with a loop electrosurgical excision procedure in women with HR-HPV positive and cervical high-grade squamous intraepithelial les
    BMC Cancer. 2024;24:1496.
    PubMed     Abstract available
    
    
    November 2024
95. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Correction: Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1478.
    PubMed    
    
    
    
96. CHEN C, Zhu B, Wang Y, Zhao Y, et al
    Incidence and risk factor of blood transfusion after abdominal radical hysterectomy for cervical cancer: a 10-year retrospective study of the US nationwide inpatient sample.
    BMC Cancer. 2024;24:1454.
    PubMed     Abstract available
    
    
    
97. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1438.
    PubMed     Abstract available
    
    
    
98. CHEN H, Ma Y, Wang D, Wu H, et al
    The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer.
    BMC Cancer. 2024;24:1405.
    PubMed     Abstract available
    
    
    
99. CHEN X, Jiang H, Xu H, Wang L, et al
    Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).
    BMC Cancer. 2024;24:1385.
    PubMed     Abstract available
    
    
    
100. EFFAH K, Tekpor E, Wormenor CM, Allotey J, et al
     Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study.
     BMC Cancer. 2024;24:1367.
     PubMed     Abstract available
     
     
     
101. ITO H, Yokoyama Y, Kyo S, Mandai M, et al
     Interim analysis of robot-assisted radical hysterectomy in Japan: a multicenter, prospective interventional single-arm clinical trial.
     BMC Cancer. 2024;24:1360.
     PubMed     Abstract available
     
     
     
102. DEDEY F, Nsaful J, Nartey E, Labi J, et al
     Assessing the impact of cervical cancer education in two high schools in Ghana.
     BMC Cancer. 2024;24:1359.
     PubMed     Abstract available
     
     
     
103. TAO H, Yu F, Yang L, Pei X, et al
     Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population.
     BMC Cancer. 2024;24:1352.
     PubMed     Abstract available
     
     
     October 2024
104. REMMEL ML, Suija K, Raudne R, Tisler A, et al
     Women's perspectives on the acceptability of risk-based cervical cancer screening.
     BMC Cancer. 2024;24:1314.
     PubMed     Abstract available
     
     
     
105. MEKONEN EG, Gebrehana DA, Tamir TT
     Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys.
     BMC Cancer. 2024;24:1304.
     PubMed     Abstract available
     
     
     
106. YIRSAW AN, Tefera M, Bogale EK, Anagaw TF, et al
     Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:1294.
     PubMed     Abstract available
     
     
     
107. TURNA M, Rzazade R, Kucukmorkoc E, Kucuk N, et al
     Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
     BMC Cancer. 2024;24:1281.
     PubMed     Abstract available
     
     
     
108. FENG L, Shi Q, Wang S, Zhao Y, et al
     The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study.
     BMC Cancer. 2024;24:1267.
     PubMed     Abstract available
     
     
     
109. LI M, Xu T, Yang R, Wang X, et al
     Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
     BMC Cancer. 2024;24:1258.
     PubMed     Abstract available
     
     
     
110. RASEKHI KAZERUNI A, Babaei N, Esmaeili Gouvarchin Ghaleh H, Doosti A, et al
     Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model.
     BMC Cancer. 2024;24:1253.
     PubMed     Abstract available
     
     
     September 2024
111. LUO H, Lian Y, Tao H, Zhao Y, et al
     Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
     BMC Cancer. 2024;24:1171.
     PubMed     Abstract available
     
     
     
112. FANG C, Liu S, Xia J, Wu X, et al
     Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.
     BMC Cancer. 2024;24:1170.
     PubMed     Abstract available
     
     
     
113. PENG L, Ai C, Dou Z, Li K, et al
     Altered microbial diversity and composition of multiple mucosal organs in cervical cancer patients.
     BMC Cancer. 2024;24:1154.
     PubMed     Abstract available
     
     
     
114. ZHAO YC, Li YF, Qiu L, Jin SZ, et al
     SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration.
     BMC Cancer. 2024;24:1133.
     PubMed     Abstract available
     
     
     
115. DABOUS E, Alalem M, Awad AM, Elawdan KA, et al
     Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells.
     BMC Cancer. 2024;24:1091.
     PubMed     Abstract available
     
     
     
116. FU J, Xu X, Tian M, Wang H, et al
     The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis.
     BMC Cancer. 2024;24:1093.
     PubMed     Abstract available
     
     
     August 2024
117. TAO H, Chen Z, Yao B, Ren X, et al
     Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice.
     BMC Cancer. 2024;24:1060.
     PubMed     Abstract available
     
     
     
118. HAILEGEBIREAL AH, Bizuayehu HM, Tirore LL
     Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic and Health Survey.
     BMC Cancer. 2024;24:1050.
     PubMed     Abstract available
     
     
     
119. YE Y, Lian R, Li Z, Chen X, et al
     Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study.
     BMC Cancer. 2024;24:1005.
     PubMed     Abstract available
     
     
     
120. ARROSSI S, Straw C, Sanchez Antelo V, Paolino M, et al
     Implementation of WHO guidelines for cervical cancer screening, diagnosis and treatment: knowledge and perceptions of health providers from Argentina.
     BMC Cancer. 2024;24:996.
     PubMed     Abstract available
     
     
     
121. MON HM, Robb KA, Demou E
     Effectiveness of workplace cancer screening interventions: a systematic review.
     BMC Cancer. 2024;24:999.
     PubMed     Abstract available
     
     
     
122. LAKEW G, Yirsaw AN, Berhie AY, Belayneh AG, et al
     Cervical cancer screening practice and associated factors among female health care professionals in Ethiopia 2024: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:986.
     PubMed     Abstract available
     
     
     
123. BOUSKILL K, Wagner GJ, Gizaw M, Matovu JK, et al
     Understanding women's and men's perspectives on cervical cancer screening in Uganda: a qualitative study.
     BMC Cancer. 2024;24:933.
     PubMed     Abstract available
     
     
     July 2024
124. ANABA EA, Alor SK, Badzi CD, Mbuwir CB, et al
     Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.
     BMC Cancer. 2024;24:920.
     PubMed     Abstract available
     
     
     
125. HUANG M, Wang T, Li M, Qin M, et al
     Evaluating PAX1 methylation for cervical cancer screening triage in non-16/18 hrHPV-positive women.
     BMC Cancer. 2024;24:913.
     PubMed     Abstract available
     
     
     
126. YANG X, Zhou M, Luan Y, Li K, et al
     Identification of key genes associated with cervical cancer based on bioinformatics analysis.
     BMC Cancer. 2024;24:897.
     PubMed     Abstract available
     
     
     
127. CONG H, Yang X, Li Z, Li Z, et al
     Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities.
     BMC Cancer. 2024;24:871.
     PubMed     Abstract available
     
     
     
128. DE LA CRUZ-LOPEZ KG, Alvarado-Ortiz E, Valencia-Gonzalez HA, Beltran-Anaya FO, et al
     Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
     BMC Cancer. 2024;24:853.
     PubMed     Abstract available
     
     
     
129. YOU J, Yuan Y, Gu X, Wang W, et al
     Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.
     BMC Cancer. 2024;24:833.
     PubMed     Abstract available
     
     
     
130. SERMAN F, Lisembard G, Sahraoui M, Berkhout C, et al
     A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.
     BMC Cancer. 2024;24:807.
     PubMed     Abstract available
     
     
     June 2024
131. QIN L, Zhang L
     The predictive value of serum inflammatory markers for the severity of cervical lesions.
     BMC Cancer. 2024;24:780.
     PubMed     Abstract available
     
     
     
132. YANG W, Jin X, Huang L, Jiang S, et al
     Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
     BMC Cancer. 2024;24:776.
     PubMed     Abstract available
     
     
     
133. OKUNADE KS, Adejimi AA, Adekanye TV, Allsop MJ, et al
     Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
     BMC Cancer. 2024;24:751.
     PubMed     Abstract available
     
     
     
134. SIFER SD
     Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study.
     BMC Cancer. 2024;24:750.
     PubMed     Abstract available
     
     
     
135. HOSKIN P, Lee M, Dunkley D, Danh M, et al
     Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
     BMC Cancer. 2024;24:702.
     PubMed     Abstract available
     
     
     
136. ALI B, Galbarczyk A, Jasienska G, Ba-Break M, et al
     Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women.
     BMC Cancer. 2024;24:695.
     PubMed     Abstract available
     
     
     
137. FEREDE YA, Tassew WC, Zeleke AM
     Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
     BMC Cancer. 2024;24:678.
     PubMed     Abstract available
     
     
     May 2024
138. LI J, Yang Z, Wang T, Li M, et al
     Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
     BMC Cancer. 2024;24:667.
     PubMed     Abstract available
     
     
     
139. AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
     Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
     BMC Cancer. 2024;24:660.
     PubMed     Abstract available
     
     
     
140. PAN XB, Lu Y, Wei YS, Yao DS, et al
     Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
     BMC Cancer. 2024;24:655.
     PubMed     Abstract available
     
     
     
141. BUYUKBAYRAM ME, Hannarici Z, Turhan A, Caglar AA, et al
     A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
     BMC Cancer. 2024;24:626.
     PubMed     Abstract available
     
     
     
142. LYONNAIS E, Vigoureux S, Blondel B, Wylomanski S, et al
     Women's country of birth and failure to catch up an overdue cervical cancer cytological screening participation during pregnancy in France, an observational study based on survey sources.
     BMC Cancer. 2024;24:595.
     PubMed     Abstract available
     
     
     
143. WU Y, Jiang P, Chen Z, Li W, et al
     Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
     BMC Cancer. 2024;24:589.
     PubMed     Abstract available
     
     
     
144. LEI L, Zhang L, Zheng Y, Ma W, et al
     Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
     BMC Cancer. 2024;24:575.
     PubMed     Abstract available
     
     
     
145. ZHAO A, Pan Y, Gao Y, Zhi Z, et al
     MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
     BMC Cancer. 2024;24:559.
     PubMed     Abstract available
     
     
     April 2024
146. ZHOU Y, Wang W, Tang J, Hu K, et al
     Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
     BMC Cancer. 2024;24:548.
     PubMed     Abstract available
     
     
     
147. ADAM JA, Poel E, van Eck Smit BLF, Mom CH, et al
     [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
     BMC Cancer. 2024;24:513.
     PubMed     Abstract available
     
     
     
148. GU Z, Yang C, Zhang K, Wu H, et al
     Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
     BMC Cancer. 2024;24:492.
     PubMed     Abstract available
     
     
     
149. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
     Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
     BMC Cancer. 2024;24:450.
     PubMed     Abstract available
     
     
     
150. LI Z, Zhou G, Jiang L, Wang M, et al
     Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
     BMC Cancer. 2024;24:401.
     PubMed     Abstract available
     
     
     March 2024
151. LI X, Zhao Y, Xiang F, Zhang X, et al
     Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
     BMC Cancer. 2024;24:381.
     PubMed     Abstract available
     
     
     
152. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
     Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
     BMC Cancer. 2024;24:375.
     PubMed     Abstract available
     
     
     
153. CUI X, Wang H, Chen M, Seery S, et al
     Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
     BMC Cancer. 2024;24:349.
     PubMed     Abstract available
     
     
     
154. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
     Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
     BMC Cancer. 2024;24:351.
     PubMed     Abstract available
     
     
     
155. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
     Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
     BMC Cancer. 2024;24:308.
     PubMed     Abstract available
     
     
     
156. ZHANG Y, Liu S, Chen M, Ou Q, et al
     Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
     BMC Cancer. 2024;24:288.
     PubMed     Abstract available
     
     
     February 2024
157. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
     Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
     BMC Cancer. 2024;24:259.
     PubMed     Abstract available
     
     
     
158. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
     Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
     BMC Cancer. 2024;24:243.
     PubMed     Abstract available
     
     
     
159. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
     Using administrative registries as a source for population-based cancer incidence and mortality.
     BMC Cancer. 2024;24:232.
     PubMed    
     
     
     
160. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
     Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
     BMC Cancer. 2024;24:217.
     PubMed     Abstract available
     
     
     
161. XIAO L, Dong X, Sun J, Zhang X, et al
     Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
     BMC Cancer. 2024;24:169.
     PubMed     Abstract available
     
     
     
162. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
     Sociodemographic characteristics and their association with survival in women with cervical cancer.
     BMC Cancer. 2024;24:161.
     PubMed     Abstract available
     
     
     January 2024
163. LIU H, Cui Y, Chang C, Zhou Z, et al
     Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
     BMC Cancer. 2024;24:150.
     PubMed     Abstract available
     
     
     
164. PAN XB, Lu Y, Wei YS, Yao DS, et al
     Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
     BMC Cancer. 2024;24:106.
     PubMed     Abstract available
     
     
     
165. YU JH, Tong CJ, Huang QD, Ye YL, et al
     Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
     BMC Cancer. 2024;24:88.
     PubMed     Abstract available
     
     
     
166. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
     Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
     BMC Cancer. 2024;24:66.
     PubMed     Abstract available
     
     
     
167. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
     Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
     BMC Cancer. 2024;24:38.
     PubMed     Abstract available
     
     
     December 2023
168. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
     Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
     BMC Cancer. 2023;23:1228.
     PubMed     Abstract available
     
     
     
169. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
     Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
     BMC Cancer. 2023;23:1216.
     PubMed     Abstract available
     
     
     
170. KONG L, Xiao X, Xu T, Wan R, et al
     Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
     BMC Cancer. 2023;23:1211.
     PubMed     Abstract available
     
     
     November 2023
171. CHENG Z, Wang H, Yang Z, Li J, et al
     LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
     BMC Cancer. 2023;23:1128.
     PubMed     Abstract available
     
     
     
172. ZHANG H, Yang Y, Xing W, Li Y, et al
     Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
     BMC Cancer. 2023;23:1124.
     PubMed     Abstract available
     
     
     
173. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
     HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
     BMC Cancer. 2023;23:1118.
     PubMed     Abstract available
     
     
     
174. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
     Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
     BMC Cancer. 2023;23:1104.
     PubMed     Abstract available
     
     
     
175. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
     Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
     BMC Cancer. 2023;23:1072.
     PubMed     Abstract available
     
     
     
176. LI X, Wei X, Liu X, Wang N, et al
     The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
     BMC Cancer. 2023;23:1052.
     PubMed     Abstract available
     
     
     October 2023
177. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
     Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
     BMC Cancer. 2023;23:1034.
     PubMed     Abstract available
     
     
     
178. LV N, Zhao Y, Song Y, Ji M, et al
     Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
     BMC Cancer. 2023;23:1022.
     PubMed     Abstract available
     
     
     
179. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
     Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
     BMC Cancer. 2023;23:963.
     PubMed    
     
     
     
180. MISGUN T, Demissie DB
     Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
     BMC Cancer. 2023;23:961.
     PubMed     Abstract available
     
     
     
181. WANG J, Huang J, Ding H, Ma J, et al
     Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
     BMC Cancer. 2023;23:929.
     PubMed     Abstract available
     
     
     September 2023
182. SHAN M, Deng Y, Zou W, Fan S, et al
     Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
     BMC Cancer. 2023;23:905.
     PubMed     Abstract available
     
     
     
183. HE C, Pei C, Ma J
     Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
     BMC Cancer. 2023;23:863.
     PubMed     Abstract available
     
     
     
184. WANG F, Song S, Guo B, Li Y, et al
     Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
     BMC Cancer. 2023;23:853.
     PubMed     Abstract available
     
     
     
185. ZHU M, Li X, Feng Y, Jia T, et al
     Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
     BMC Cancer. 2023;23:845.
     PubMed     Abstract available
     
     
     
186. CHETTY-SEBASTIAN D, Assounga AG
     Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
     BMC Cancer. 2023;23:830.
     PubMed     Abstract available
     
     
     
187. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
     Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
     BMC Cancer. 2023;23:820.
     PubMed     Abstract available
     
     
     
188. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
     Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
     BMC Cancer. 2023;23:819.
     PubMed     Abstract available
     
     
     August 2023
189. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
     The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
     BMC Cancer. 2023;23:803.
     PubMed     Abstract available
     
     
     
190. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
     Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
     BMC Cancer. 2023;23:730.
     PubMed     Abstract available
     
     
     July 2023
191. ZHANG C, Gu L, Xiao J, Jin F, et al
     Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
     BMC Cancer. 2023;23:684.
     PubMed     Abstract available
     
     
     
192. MUSA J, Maiga M, Green SJ, Magaji FA, et al
     Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
     BMC Cancer. 2023;23:683.
     PubMed     Abstract available
     
     
     
193. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
     Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
     BMC Cancer. 2023;23:653.
     PubMed     Abstract available
     
     
     
194. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
     Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
     BMC Cancer. 2023;23:631.
     PubMed     Abstract available
     
     
     June 2023
195. PENG H, Zhang J, Xu N, Zhou Y, et al
     Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
     BMC Cancer. 2023;23:588.
     PubMed     Abstract available
     
     
     May 2023
196. WU J, Guo Q, Zhu J, Wu Y, et al
     Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
     BMC Cancer. 2023;23:485.
     PubMed     Abstract available
     
     
     
197. JIANG Y, Wang J, Jiang P, Wang X, et al
     Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
     BMC Cancer. 2023;23:481.
     PubMed     Abstract available
     
     
     
198. BELAY AS, Asmare WN, Kassie A
     Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
     BMC Cancer. 2023;23:472.
     PubMed     Abstract available
     
     
     
199. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
     Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
     BMC Cancer. 2023;23:466.
     PubMed     Abstract available
     
     
     
200. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
     Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
     BMC Cancer. 2023;23:428.
     PubMed     Abstract available
     
     
     
201. YE Y, Li Z, Kang S, Yang Y, et al
     Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
     BMC Cancer. 2023;23:421.
     PubMed     Abstract available
     
     
     
202. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
     Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
     BMC Cancer. 2023;23:405.
     PubMed     Abstract available
     
     
     April 2023
203. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
     Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
     BMC Cancer. 2023;23:385.
     PubMed     Abstract available
     
     
     
204. GAN Q, Huang X, Zhao W, Liu H, et al
     AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
     BMC Cancer. 2023;23:364.
     PubMed     Abstract available
     
     
     
205. RAHIMI M, Akbari A, Asadi F, Emami H, et al
     Cervical cancer survival prediction by machine learning algorithms: a systematic review.
     BMC Cancer. 2023;23:341.
     PubMed     Abstract available
     
     
     March 2023
206. ZHANG H, Wang X, Li Y, Bai Y, et al
     The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
     BMC Cancer. 2023;23:222.
     PubMed     Abstract available
     
     
     February 2023
207. QIN D, Bai A, Xue P, Seery S, et al
     Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.
     BMC Cancer. 2023;23:187.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum